NCT04823286

Brief Summary

There is wide evidence regarding the weak points of end-stage Chronic kidney disease (CKD) patients in hemodialysis, and they include three intervention aspects: exercise, nutrition and psychological support. Evidence shows that exercise for patients in hemodialysis results in increased survival rate, functional capacity, strength and health-related quality of life. Additionally, different studies have shown the benefits of psychological interventions and the positive effect of educational programs on nutritional care for patients in hemodialysis. Despite the well-known benefits of exercise, this kind of programs are not being implemented in the routine clinical care of hemodialysis patients. Thus, the GoodRENal project aims to promote healthy lifestyles among dialysis patients in a holistic approach that combines exercise, nutrition and psychological wellbeing plus cognitive functioning addressing adult learners. The project will, in phase 1, explore barriers and facilitators of patients, carers and health professionals towards healthy lifestyle (physical activity, nutrition and psychological well being). In phase 2, the project will develop a health virtual platform including these three dimensions of cares. In summary, the project outputs will be:

  1. 1.A didactic content in a modular platform to create an educational program for integrated treatments in patients with dialysis
  2. 2.A guideline to promote healthy lifestyles among dialysis patients for health care providers
  3. 3.A guideline to promote e healthy lifestyles among dialysis patients for patients and formal - nonformal carers

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
4 countries

8 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Mar 2021Aug 2026

First Submitted

Initial submission to the registry

January 28, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 30, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

March 31, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Expected
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

2.3 years

First QC Date

January 28, 2021

Last Update Submit

January 21, 2026

Conditions

Keywords

exercisephysical functionhealth related quality of lifenutritionpsychological wellbeing

Outcome Measures

Primary Outcomes (1)

  • Change from baseline distance walked assessed by the 6 minutes walk test at 12 weeks

    More meters walked in 6 minutes mean a better walking capacity

    Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention

Secondary Outcomes (21)

  • Change from baseline health-related quality of life assessed by the Short Form 36 questionnaire at 12 weeks

    Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention

  • Change from baseline stance from a chair capacity assessed by the sit to stand 10 at 12 weeks

    Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention

  • Change from baseline usual gait speed assessed by a 4 meters gait speed test at 12 weeks

    Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention

  • Change from baseline handgrip strength assessed by a handgrip dinamometer at 12 weeks

    Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention

  • Change from baseline lower limbs strength assessed by a dinamometer at 12 weeks

    Baseline, after 12 weeks of intervention, 12 weeks follow-up after the end of the intervention

  • +16 more secondary outcomes

Study Arms (2)

Virtual reality health platform during hemodialysis

EXPERIMENTAL

During 12 weeks subjects will use a VR platform during hemodialysis. The intervention will be virtual reality exercise, nutritional advice and psychological wellbeing support plus cognitive training.

Other: Virtual reality health platform during hemodialysis

Control group-usual care

NO INTERVENTION

During 12 weeks subjects will carry on with the usual care in the hemodialysis unit

Interventions

Subjects will play a virtual reality game specially adapted for subjects undertaking hemodialysis. The game will also aim at providing nutritional advice, and improving psychological wellbeing and cognitive function.

Virtual reality health platform during hemodialysis

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients on hemodialysis medically stable
  • Ability to walk to walk at least a few steps, even if walking aids like canes or a walker ar needed
  • Life expectancy greater than 6 months

You may not qualify if:

  • Myocardial infarction in the previous 6 weeks
  • Angina unstable on exercise or at rest
  • Brain injury derived from a cardiovascular problem. Cerebral vascular disease such as stroke in the last 6 months or with relevant sequelae in lower limb mobility presenting hemiparesia.
  • Life expectancy less than 6 months
  • Cognitive impairment
  • Language barriers
  • Illiteracy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

KU Leuven

Leuven, 3000, Belgium

Location

Aristotle University of Thessaloniki

Thessaloniki, 57001, Greece

Location

Consorci Sanitari de Terrassa

Terrassa, Barcelona, Spain

Location

Hospital de Manises

Manises, Valencia, 46940, Spain

Location

Universitat de Valencia

Valencia, Valencia, 46010, Spain

Location

Universitat Politécnica de Valéncia

Valencia, Valencia, 46022, Spain

Location

Skane Univeristy Hospital

Lund, Sweden

Location

Karolinska Institute

Stockholm, 14186, Sweden

Location

Related Publications (6)

  • Segura-Orti E, Gordon PL, Doyle JW, Johansen KL. Correlates of Physical Functioning and Performance Across the Spectrum of Kidney Function. Clin Nurs Res. 2018 Jun;27(5):579-596. doi: 10.1177/1054773816689282. Epub 2017 Jan 23.

    PMID: 28114792BACKGROUND
  • Segura-Orti E, Martinez-Olmos FJ. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys Ther. 2011 Aug;91(8):1244-52. doi: 10.2522/ptj.20100141. Epub 2011 Jun 30.

    PMID: 21719637BACKGROUND
  • Segura-Orti E, Johansen KL. Exercise in end-stage renal disease. Semin Dial. 2010 Jul-Aug;23(4):422-30. doi: 10.1111/j.1525-139X.2010.00766.x.

    PMID: 20701722BACKGROUND
  • Segura-Orti E. [Exercise in haemodyalisis patients: a literature systematic review]. Nefrologia. 2010;30(2):236-46. doi: 10.3265/Nefrologia.pre2010.Jan.10229. Epub 2010 Jan 21. Spanish.

    PMID: 20098466BACKGROUND
  • Segura-Orti E, Kouidi E, Lison JF. Effect of resistance exercise during hemodialysis on physical function and quality of life: randomized controlled trial. Clin Nephrol. 2009 May;71(5):527-37. doi: 10.5414/cnp71527.

    PMID: 19473613BACKGROUND
  • Segura-Orti E, Rodilla-Alama V, Lison JF. [Physiotherapy during hemodialysis: results of a progressive resistance-training programme]. Nefrologia. 2008;28(1):67-72. Spanish.

    PMID: 18336134BACKGROUND

MeSH Terms

Conditions

Kidney Failure, ChronicRenal Insufficiency, ChronicMotor Activity

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Eva SEGURA-ORTÍ

    Universidad CEU Cardenal Herrera, UCH CEU

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
A team of assessors, different to the researchers implementing the exercise, will record all dependent variables. A blind researcher will randomize participants
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized into one of two groups, intradialysis virtual reality platform or usual care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 28, 2021

First Posted

March 30, 2021

Study Start

March 31, 2021

Primary Completion

July 31, 2023

Study Completion (Estimated)

August 31, 2026

Last Updated

January 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations